Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State
Pediatr Pulmonol
.
2024 May;59(5):1511-1513.
doi: 10.1002/ppul.26928.
Epub 2024 Mar 1.
Authors
Catherine Kier
1
,
Denise M Kay
2
,
Elinor Langfelder-Schwind
3
,
Danielle M Goetz
4
,
Maria Berdella
3
,
Joan K DeCelie-Germana
5
,
Zafer N Soultan
6
,
Michele Caggana
2
,
Christopher N Fortner
6
,
Robert Giusti
7
,
Robert Kaslovsky
8
,
Karen Voter
9
,
John J Welter
10
;
New York State Cystic Fibrosis Newborn Screening Consortium
;
Hossein Sadeghi
11
Affiliations
1
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
2
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
3
Lenox Hill Hospital, Northwell Health System, New York, New York, USA.
4
University at Buffalo School of Medicine, Buffalo, New York, USA.
5
Cohen Children's Medical Center, Northwell Health System, New Hyde Park, New York, USA.
6
Upstate Medical University, Syracuse, New York, USA.
7
NYU Langone Health, New York, New York, USA.
8
Albany Medical College, Albany, New York, USA.
9
Strong Memorial Hospital, University of Rochester Medical Center, Rochester, New York, USA.
10
Division of Pediatric Pulmonology, New York Medical College, Valhalla, New York, USA.
11
Columbia University Irving Medical Center, New York, New York, USA.
PMID:
38426813
DOI:
10.1002/ppul.26928
No abstract available
Publication types
Letter
MeSH terms
Congenital Bone Marrow Failure Syndromes*
Female
Follow-Up Studies
Humans
Infant, Newborn
Male
New York